Cash flow Sernova Toronto S.E.

Stocks

SVA

CA81732W1041

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 10:55:42 2026-08-18 EDT			5-day change	1st Jan Change
0.1050 ^CAD	+5.00%		-9.09%	-23.08%

06-17	Sernova's Autologous Islet Transplantation Gets Orphan Drug Designation For Type 3c Diabetes Prevention	MT
06-11	Sernova Biotherapeutics Inc Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2026	CI

6792d0bf.R3v3ivDLvuOVBjf4ktDLwu2X_TESv_1uyKamU3Ye-Kg.HU2S5a-I2KXwMl-g_bG89pvysUQk3K8mq8iQKU56nu4NLsbIqJjwgNp0Dw

Published financial data: SERNOVA

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: October	2021	2022	2023	2024	2025
Selling General & Admin Expenses, Total	2.3M	7.86M	8.46M	8.97M	7.52M
R&D Expenses	4.64M	16.9M	32.04M	22.69M	7.5M
Other Operating Expenses, Total	6.94M	24.75M	40.5M	31.66M	15.02M
Operating Income	-6.94M	-24.75M	-40.5M	-31.66M	-15.02M
Interest Expense, Total	-34.37K	-51.18K	-32.08K	-587K	-755K
Interest And Investment Income	70.55K	577K	1.5M	388K	25.63K
Net Interest Expenses	36.18K	526K	1.47M	-198K	-729K
Currency Exchange Gains (Loss)	-41.22K	-126K	35.93K	-342K	-37.05K
Other Non Operating Income (Expenses)	-24K	-66.82K	-	-	-
EBT, Excl. Unusual Items	-6.97M	-24.42M	-39M	-32.2M	-15.79M
Gain (Loss) On Sale Of Assets	-	-	-	18.86K	55.22K
EBT, Incl. Unusual Items	-6.97M	-24.42M	-39M	-32.19M	-15.73M
Income Tax Expense	-	-	-	7K	9.43K
Earnings From Continuing Operations	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Net Income to Company	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Net Income - (IS)	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Net Income to Common Incl Extra Items	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Net Income to Common Excl. Extra Items	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Per Share Items
Net EPS - Basic	-0.03	-0.09	-0.13	-0.1	-0.05
Basic EPS - Continuing Operations	-0.03	-0.09	-0.13	-0.1	-0.05
Basic Weighted Average Shares Outstanding	246M	274M	303M	307M	328M
Net EPS - Diluted	-0.03	-0.09	-0.13	-0.1	-0.05
Diluted EPS - Continuing Operations	-0.03	-0.09	-0.13	-0.1	-0.05
Diluted Weighted Average Shares Outstanding	246M	274M	303M	307M	328M
Normalized Basic EPS	-0.02	-0.06	-0.08	-0.07	-0.03
Normalized Diluted EPS	-0.02	-0.06	-0.08	-0.07	-0.03
Supplemental Items
EBITDA	-6.69M	-24.45M	-40.19M	-31.25M	-14.77M
EBITA	-6.74M	-24.55M	-40.3M	-31.35M	-15.02M
EBIT	-6.94M	-24.75M	-40.5M	-31.66M	-15.02M
Effective Tax Rate - (Ratio)	-	-	-	-0.02	-0.06
Total Current Taxes	-	-	-	7K	79.43K
Total Deferred Taxes	-	-	-	-	-70K
Normalized Net Income	-4.35M	-15.26M	-24.37M	-20.13M	-9.87M
Interest on Long-Term Debt	58.37K	118K	32.08K	587K	46.69K
Supplemental Operating Expense Items
General and Administrative Expenses	2.3M	7.86M	8.46M	8.97M	7.52M
Research And Development Expense From Footnotes	5.76M	17.57M	32.67M	22.87M	7.6M
Stock-Based Comp., R&D Exp. (Total)	96.46K	3.7M	1.55M	1.07M	58.44K
Stock-Based Comp., G&A Exp. (Total)	122K	3.75M	2.35M	675K	2.24M
Stock-Based Comp., Other (Total)	-	-	-	-	203K
Total Stock-Based Compensation	218K	7.45M	3.9M	1.75M	2.51M

Fiscal Period: October	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	27.87M	3.78M	8.72M	6.01M	265K
Short Term Investments	-	46M	11.08M	-	-
Total Cash And Short Term Investments	27.87M	49.78M	19.81M	6.01M	265K
Other Receivables	449K	1.15M	1.05M	298K	123K
Total Receivables	449K	1.15M	1.05M	298K	123K
Prepaid Expenses	4.2K	168K	165K	159K	135K
Total Current Assets	28.33M	51.09M	21.02M	6.47M	523K
Gross Property Plant And Equipment	860K	1.05M	1.01M	1.43M	213K
Accumulated Depreciation	-295K	-398K	-506K	-600K	-195K
Net Property Plant And Equipment	565K	654K	507K	834K	17.72K
Other Intangibles, Total	717K	517K	317K	0	-
Other Long-Term Assets, Total	212K	224K	259K	224K	224K
Total Assets	29.82M	52.48M	22.11M	7.53M	764K
Liabilities
Accounts Payable, Total	380K	3.61M	6.85M	17.24M	17.67M
Accrued Expenses, Total	909K	987K	2.51M	2.67M	3.4M
Short-term Borrowings	-	-	-	-	3.73M
Current Portion of Leases	117K	140K	136K	101K	-
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	69.89K	-	95.01K	-	-
Total Current Liabilities	1.48M	4.74M	9.59M	20.02M	24.8M
Long-Term Debt	-	-	-	-	1.04M
Long-Term Leases	276K	136K	-	468K	-
Total Liabilities	1.75M	4.88M	9.59M	20.48M	25.84M
Common Stock, Total	74.01M	111M	111M	117M	119M
Additional Paid In Capital	5.11M	12.49M	19.69M	20.69M	21.79M
Retained Earnings	-54.75M	-79.17M	-118M	-150M	-166M
Comprehensive Income and Other	3.69M	3.3M	-	34.42K	537K
Total Common Equity	28.07M	47.61M	12.51M	-12.96M	-25.08M
Total Equity	28.07M	47.61M	12.51M	-12.96M	-25.08M
Total Liabilities And Equity	29.82M	52.48M	22.11M	7.53M	764K
Supplemental Items
ECS Total Shares Outstanding on Filing Date	262M	303M	303M	328M	337M
ECS Total Common Shares Outstanding	261M	303M	303M	325M	333M
Book Value / Share	0.11	0.16	0.04	-0.04	-0.08
Tangible Book Value	27.35M	47.09M	12.2M	-12.96M	-25.08M
Tangible Book Value Per Share	0.1	0.16	0.04	-0.04	-0.08
Total Debt	393K	276K	136K	570K	4.77M
Net Debt	-27.48M	-49.5M	-19.67M	-5.44M	4.51M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	471K	800K	900K	900K	213K
Full Time Employees	-	-	-	17	8

Fiscal Period: October	2021	2022	2023	2024	2025
Net Income	-6.97M	-24.42M	-39M	-32.19M	-15.74M
Depreciation & Amortization - CF	67.17K	240K	246K	224K	343K
Amortization of Goodwill and Intangible Assets - (CF)	200K	200K	200K	317K	-
Depreciation & Amortization, Total	267K	440K	446K	540K	343K
(Gain) Loss From Sale Of Asset	-	-	-	-18.86K	-55.22K
Stock-Based Compensation (CF)	218K	7.45M	3.9M	1.75M	2.51M
Other Operating Activities, Total	-881K	-839K	-676K	-132K	306K
Change In Accounts Receivable	-89.8K	-195K	230K	562K	175K
Change In Accounts Payable	462K	3.31M	4.75M	10.59M	1.54M
Change in Other Net Operating Assets	145K	-164K	3.35K	5.49K	24.16K
Cash from Operations	-6.84M	-14.42M	-30.34M	-18.9M	-10.91M
Capital Expenditure	-17.23K	-329K	-99.26K	-	-
Sale of Property, Plant, and Equipment	-	-	-	-	24.96K
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-46M	34.92M	11.08M	-
Other Investing Activities, Total	-212K	-12.31K	-35.3K	35.3K	-
Cash from Investing	-229K	-46.34M	34.78M	11.12M	24.96K
Long-Term Debt Issued, Total	-	-	-	-	4.94M
Total Debt Issued	-	-	-	-	4.94M
Long-Term Debt Repaid, Total	-28K	-169K	-172K	-169K	-113K
Total Debt Repaid	-28K	-169K	-172K	-169K	-113K
Issuance of Common Stock	29.9M	36.55M	-	5.23M	267K
Other Financing Activities, Total	1.12M	279K	675K	7.9K	46.59K
Cash from Financing	31M	36.66M	503K	5.07M	5.14M
Net Change in Cash	23.92M	-24.1M	4.95M	-2.71M	-5.75M
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	-	9.4K
Levered Free Cash Flow	-3.21M	-5.56M	-16.13M	-6.65M	-5.66M
Unlevered Free Cash Flow	-3.18M	-5.53M	-16.11M	-6.29M	-5.19M
Change In Net Working Capital	-683K	-2.38M	-4.95M	-11.22M	-1.35M
Net Debt Issued / Repaid	-28K	-169K	-172K	-169K	4.82M

Fiscal Period: October	2021	2022	2023	2024	2025
Profitability
Return on Assets	-24.39	-37.59	-67.87	-133.56	-226.48
Return on Total Capital	-26.03	-40.53	-83.63	-14.99K	57.45
Return On Equity %	-43.25	-64.54	-129.73	14.56K	82.79
Return on Common Equity	-43.25	-64.54	-129.73	14.56K	82.79
Short Term Liquidity
Current Ratio	19.19	10.78	2.19	0.32	0.02
Quick Ratio	19.19	10.74	2.17	0.32	0.02
Operating Cash Flow to Current Liabilities	-4.64	-3.04	-3.16	-0.94	-0.44
Long Term Solvency
Total Debt/Equity	1.4	0.58	1.09	-4.4	-19.04
Total Debt / Total Capital	1.38	0.58	1.08	-4.6	-23.51
LT Debt/Equity	0.98	0.29	-	-3.62	-4.16
Long-Term Debt / Total Capital	0.97	0.28	-	-3.78	-5.14
Total Liabilities / Total Assets	5.87	9.29	43.39	272.13	3.38K
EBIT / Interest Expense	-201.81	-483.61	-1.26K	-53.95	-19.9
EBITDA / Interest Expense	-194.03	-475.02	-1.25K	-53.03	-19.45
(EBITDA - Capex) / Interest Expense	-194.53	-481.45	-1.25K	-53.03	-19.45
Total Debt / EBITDA	-0.06	-0.01	-0	-0.02	-0.33
Net Debt / EBITDA	4.12	2.04	0.49	0.17	-0.31
Total Debt / (EBITDA - Capex)	-0.06	-0.01	-0	-0.02	-0.33
Net Debt / (EBITDA - Capex)	4.11	2.01	0.49	0.17	-0.31
Growth Over Prior Year
EBITDA, 1 Yr. Growth %	30.63	265.37	64.38	-22.24	-52.75
EBITA, 1 Yr. Growth %	30.14	264.49	64.14	-22.22	-52.08
EBIT, 1 Yr. Growth %	31.88	256.86	63.62	-21.82	-52.55
Earnings From Cont. Operations, 1 Yr. Growth %	30.9	250.59	59.69	-17.45	-51.1
Net Income, 1 Yr. Growth %	30.9	250.59	59.69	-17.45	-51.1
Normalized Net Income, 1 Yr. Growth %	30.9	250.59	59.69	-17.42	-50.97
Diluted EPS Before Extra, 1 Yr. Growth %	5.18	214.62	44.04	-18.43	-54.27
Net Property, Plant and Equip., 1 Yr. Growth %	177.58	15.77	-22.37	64.34	-97.87
Total Assets, 1 Yr. Growth %	420.83	76	-57.88	-65.95	-89.85
Tangible Book Value, 1 Yr. Growth %	747.32	72.17	-74.1	-206.22	93.54
Common Equity, 1 Yr. Growth %	577.19	69.62	-73.71	-203.53	93.54
Cash From Operations, 1 Yr. Growth %	73.73	110.72	110.38	-37.72	-42.27
Capital Expenditures, 1 Yr. Growth %	215.2	1.81K	-69.83	-	-
Levered Free Cash Flow, 1 Yr. Growth %	36.95	74.31	190.09	-58.76	-14.93
Unlevered Free Cash Flow, 1 Yr. Growth %	36.27	73.65	191.41	-60.99	-17.47
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	30.22	118.47	145.07	13.06	-39.39
EBITA, 2 Yr. CAGR %	29.64	117.79	144.59	12.99	-38.95
EBIT, 2 Yr. CAGR %	31.55	116.94	141.64	13.1	-39.1
Earnings From Cont. Operations, 2 Yr. CAGR %	32.44	114.22	136.61	14.81	-36.46
Net Income, 2 Yr. CAGR %	32.44	114.22	136.61	14.81	-36.46
Normalized Net Income, 2 Yr. CAGR %	32.44	114.22	136.61	14.84	-36.37
Diluted EPS Before Extra, 2 Yr. CAGR %	12.09	81.91	112.88	8.4	-38.92
Net Property, Plant and Equip., 2 Yr. CAGR %	49.84	79.26	-5.2	12.95	-81.31
Total Assets, 2 Yr. CAGR %	131.41	202.77	-13.9	-62.13	-81.41
Tangible Book Value, 2 Yr. CAGR %	136.7	281.95	-33.22	-47.55	43.38
Common Equity, 2 Yr. CAGR %	139.79	238.91	-33.23	-47.83	41.56
Cash From Operations, 2 Yr. CAGR %	27.77	91.34	110.55	14.47	-40.04
Capital Expenditures, 2 Yr. CAGR %	-15.27	675.82	140.02	-	-
Levered Free Cash Flow, 2 Yr. CAGR %	20.96	54.14	124.87	9.38	-40.77
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.68	53.83	124.95	6.63	-43.26
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	22.48	83.66	98.71	67.15	-15.47
EBITA, 3 Yr. CAGR %	22.04	82.97	98.2	66.95	-15.11
EBIT, 3 Yr. CAGR %	23.23	83.47	97.47	65.88	-15.33
Earnings From Cont. Operations, 3 Yr. CAGR %	23.49	83.21	94.24	66.57	-13.61
Net Income, 3 Yr. CAGR %	23.49	83.21	94.24	66.57	-13.61
Normalized Net Income, 3 Yr. CAGR %	23.49	83.21	94.24	66.59	-13.53
Diluted EPS Before Extra, 3 Yr. CAGR %	6.95	58.12	68.29	54.62	-18.7
Net Property, Plant and Equip., 3 Yr. CAGR %	25.02	37.49	35.62	13.88	-69.96
Total Assets, 3 Yr. CAGR %	102.24	111.23	56.88	-36.8	-75.58
Tangible Book Value, 3 Yr. CAGR %	103.12	112.87	55.76	-22.05	-18.95
Common Equity, 3 Yr. CAGR %	104.88	113.65	44.53	-22.72	-19.24
Cash From Operations, 3 Yr. CAGR %	20.45	50.96	97.48	40.29	-8.89
Capital Expenditures, 3 Yr. CAGR %	-46.89	139.33	162.85	-	-
Levered Free Cash Flow, 3 Yr. CAGR %	11.72	36.41	90.31	27.76	0.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	11.57	36.24	90.34	25.45	-2.1
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	21.82	56.51	61.65	51.26	23.58
EBITA, 5 Yr. CAGR %	21.91	56.17	61.17	50.89	23.75
EBIT, 5 Yr. CAGR %	22.63	56.42	61.33	51.19	23.36
Earnings From Cont. Operations, 5 Yr. CAGR %	22.75	56.04	60.18	51.97	24.23
Net Income, 5 Yr. CAGR %	22.75	56.04	60.18	51.97	24.23
Normalized Net Income, 5 Yr. CAGR %	22.75	56.04	60.18	51.98	24.3
Diluted EPS Before Extra, 5 Yr. CAGR %	10.93	39.86	40.85	35.95	12.2
Net Property, Plant and Equip., 5 Yr. CAGR %	84.17	22.35	11.92	27.09	-38.62
Total Assets, 5 Yr. CAGR %	36.8	63.07	43.72	6.21	-33.15
Tangible Book Value, 5 Yr. CAGR %	38.44	66.77	30.17	21.56	50.68
Common Equity, 5 Yr. CAGR %	39.16	67.14	30.84	21.56	43.34
Cash From Operations, 5 Yr. CAGR %	21.8	39.39	50.6	35.14	22.59
Capital Expenditures, 5 Yr. CAGR %	-2.39	5.5	-2.91	-	-
Levered Free Cash Flow, 5 Yr. CAGR %	59.07	26	47.65	24.88	19.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	58.85	25.86	47.69	23.52	17.3